Wow AZD4066 June 2021, page-2

Everyone have misinterpreted this information

I became aware of it earlier this month when Azd0466 update was released

At the time did not want to jink share price

I believe that's why it retreated below $2

Phase 1 will continue

Even the big guns like AstraZeneca have been affected by COVID-19 when it comes to clinical trials as can be seen by the size of cohort reduced from 104 to 10

This just means (as stated by Starpharma in market sensitive announcement some weeks ago)...the trial will be expanded globally

Look forward to Viraleze™ roll out this coming week